Use of a microbubble agent to increase the effects of high intensity focused ultrasound on liver tissue.
In order to find out whether high intensity focused ultrasound (HIFU) might be useful against hepatocellular carcinoma, we analyzed the effect of a microbubble agent (Levovist) on the temperature rise and tissue necrosis induced by HIFU. Rabbits were given 7 ml Levovist (300 mg/ml) or saline intravenously. Up to six areas per rabbit liver were exposed to HIFU for 60 s (2.18 MHz, I(SPTA)=400 W/cm(2)). The volume of the tissue coagulated by HIFU was measured 10 min after the start of HIFU. HIFU-induced lesions were larger in the animals given Levovist: (mm(3), Levovist versus saline) 371+/-104 versus 166+/-71 (P<0.001). Temperatures in the animals given Levovist were also higher 60 s after the start of exposure: ( degrees C, Levovist versus saline) 20.3+/-3.5 versus 13.2+/-3.8 (P<0.001). The amount of damage differed greatly, but the pathological changes caused by HIFU with Levovist were the same as those caused by HIFU with saline. Hemorrhagic areas and implosion cysts were seen, and many cells had been disrupted or destroyed. Microbubble agents developed for diagnostic uses could also be used in anticancer therapy.
Kaneko
Yukio
Y
Department of Mechanical Engineering, The University of Tokyo, Japan.
Maruyama
Toshiyuki
T
Takegami
Kenji
K
Watanabe
Toshiaki
T
Mitsui
Hiroshi
H
Hanajiri
Kazuyuki
K
Nagawa
Hirokazu
H
Matsumoto
Yoichiro
Y
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001831:Body Temperature / Q000187:drug effects; D003287:Contrast Media; D006979:Hyperthermia, Induced; D008099:Liver / Q000000981:diagnostic imaging* / Q000473:pathology; D045423:Microbubbles; D009336:Necrosis; D011134:Polysaccharides; D011817:Rabbits; D012965:Sodium Chloride; D013997:Time Factors; D014464:Ultrasonic Therapy; D014463:Ultrasonography
D000970:Antineoplastic Agents; D003287:Contrast Media; D011134:Polysaccharides; C059891:SHU 508; D012965:Sodium Chloride
Phys Med Biol. 1991 Nov;36(11):1495-501
1754620
Radiology. 1997 Jan;202(1):195-203
8988211
Phys Ther. 2001 Jul;81(7):1351-8
11444998
Ultrasound Med Biol. 1993;19(9):803-13
8134980
Urol Res. 2004 Feb;32(1):14-9
14655029
Ultrasound Med Biol. 1998 Nov;24(9):1475-88
10385969
BMJ. 2001 May 19;322(7296):1222-5
11358777
J Pediatr Surg. 1989 Jan;24(1):30-3; discussion 33
2723989
Ultrasound Med Biol. 1996;22(9):1131-54
9123638
J Ultrasound Med. 1998 Aug;17 (8):531-3
9697961
Ultrasound Med Biol. 2001 Oct;27(10):1399-412
11731053
IEEE Trans Ultrason Ferroelectr Freq Control. 1988;35(5):578-81
18290190
Arch Surg. 1991 Aug;126(8):1002-9; discussion 1009-10
1863205
Radiology. 1983 Aug;148(2):397-401
6306721
Ultrasound Med Biol. 2004 Feb;30(2):245-60
14998677
Ultrasound Med Biol. 2003 Sep;29(9):1351-8
14553813
Eur Urol. 1993;23 Suppl 1:48-52
7685697
Urology. 1996 Feb;47(2):204-7
8607235
Ultrasound Med Biol. 2002 Jun;28(6):785-91
12113791
Ultrasound Med Biol. 1999 Jun;25(5):847-56
10414902
Ultrasound Med Biol. 2004 Jan;30(1):57-60
14962608
Br J Radiol. 2003 Sep;76(909):590-9
14500272
IEEE Trans Ultrason Ferroelectr Freq Control. 2003 Oct;50(10 ):1296-304
14609069
Arch Surg. 1973 Dec;107(6):887-91
4751833
Cancer Res. 1995 Aug 1;55(15):3346-51
7542168